What is the main business of Guerbet Poland?

The main business activity of Guerbet Poland focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 27, 2012.

Where is the headquarters located?

The headquarters is located at: Al. Jerozolimskie 162, 02-342 Warszawa.

What is the share capital?

The share capital of the company is PLN 33,000 (approx. $8,914).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

How much revenue was generated?

In 2024, the company generated total revenue of $2,434,270, representing a decrease of 4.2% compared to 2023.

Is the company profitable?

Yes, in 2024 the company was profitable, achieving a net profit of $182,505, meaning the company increased its profit by 169.9%.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $637,368 in 2024, representing 30% of all operating expenses.

Guerbet Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2012-11-27

Share capital

33 000,00 PLN

Activity description

Guerbet Poland operates in medical imaging, providing products and solutions for diagnostic and interventional radiology. Its offering also includes diagnostic imaging solutions and AI software to support oncology image interpretation.

Registered address

al. Jerozolimskie 162, 02-342 Warszawa, Poland

Website

guerbet.com

Phone

Social media

Electronic delivery address

AE:PL-99148-19477-IDFTJ-23

Financials

Revenue history (in k)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 2.51mMedianUSD 874.80kAverageUSD 20.30m

Net profit

This companyUSD 255.20kMedianUSD 28.22kAverageUSD 816.54k

Operating costs

This companyUSD 2.16mMedianUSD 805.63kAverageUSD 19.09m

Assets

This companyUSD 804.15kMedianUSD 541.73kAverageUSD 10.95m

News

Changes to the Composition of Guerbet’s Board of Directors

Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)

Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT

Industry

Bank accounts

Registered as a VAT taxpayer on 2013-05-02. Active

Deutsche Bank Polska
89 1880 0009 0000 0011 0236 5000

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

MSiG notices

Publication date	Event
May 22, 2013	Commercial Companies Code notice

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Public sector contracts

Guerbet Poland is the contractor in one public sector contract, worth PLN 8.84k.

Signed	Subject	Public buyer	Value
Jul 9, 2026	linie, strzykawka, zestaw	Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina w Rzeszowie	PLN 8,840

Public buyer	Value
Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina w Rzeszowie	PLN 8,840

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Adriano Mendes Caldas – President of the Management Board

Jérôme Estampes – Management Board Member

Joanna Monika Korycińska – Attorney-in-fact

Manner of representation

Each member of the management board is authorized to make statements on behalf of the company and represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Guerbet Sa	660	$8,914.10	100%

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Biochem PolskaS.A.	$7,311,179.43	biochempolska.pl
Mindray Medical Polandsp. z o.o.	$6,479,161.67	mindray.com
Inobesp. z o.o.	$3,086,358.88	inobe.pl
Investmed-Investcars-Adamskisp. k.	$2,859,259.00	investmed.com.pl
GWS Polandsp. z o.o.	$2,706,990.11	gwspoland.pl
Red Med Polandsp. z o.o.	$2,508,628.68	redmed.pl
Medikol Healthcaresp. z o.o.	$2,081,066.57	medikol.eu
Mercantsp. z o.o.	$1,876,335.96	mercant.pl
Meditechsp. z o.o.	$934,565.46	meditech.pl
Move-Xsp. z o.o.	$870,473.73	move-x.eu

Change history

Date	Event
2016-03-21	Name change (Mallinckrodt → Guerbet Poland)
2015-05-06	PKD change (Removed: 20.12.Z, 20.16.Z, 20.41.Z, 20.42.Z, 20.59.Z, 22.29.Z, 26.60.Z, 46.18.Z, 46.45.Z, 46.75.Z, 46.76.Z, 47.75.Z, 64.91.Z, 64.99.Z, 66.19.Z, 68.10.Z, 68.20.Z, 70.10.Z, 70.22.Z)
2014-07-01	Address change (Plac Piłsudskiego 1, 00-078, Warszawa → Al. Jerozolimskie 162, 02-342, Warszawa)
2014-03-13	Address change (Al. Jerozolimskie 162, 02-342, Warszawa → Plac Piłsudskiego 1, 00-078, Warszawa)
2013-04-29	Share capital change (5,000.00 PLN → 33,000.00 PLN)

FAQ

Last updated: 2026-10-07